Nobel Prize-winning scientist Shinya Yamanaka, facing reporters in Kyoto, decried “three misconceptions” about the induced pluripotent stem, or iPS, cells that he developed in relation to STAP cells were recently unveiled.
The Kyoto University professor said Monday that one of the misconceptions is that iPS cells have a higher risk of developing cancer than STAP cells.
While iPS has for years been a viable alternative to embryonic stem cells, which carry certain ethical challenges, a team of researchers led by Haruko Obokata, a biologist at the Riken Center for Developmental Biology in Kobe, developed STAP, or stimulus-triggered acquisition of pluripotency, cells in mice.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.